Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous arteriovenous hemofiltration in experimental iron intoxication.

W Banner1, D D Vernon, R M Ward

  • 1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City.

Critical Care Medicine
|November 1, 1989
PubMed
Summary

Continuous arteriovenous hemofiltration (CAVH) effectively removes iron-deferoxamine complexes in experimental iron intoxication. This method shows promise for managing iron poisoning by enhancing iron excretion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulation practices associated with bleeding and thrombosis in pediatric extracorporeal membrane oxygenation; a multi-center secondary analysis.

Perfusion·2022
Same author

Clinical characteristics of exposures to liquid laundry detergent packets.

Human & experimental toxicology·2019
Same author

Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same author

Fish functional traits are affected by hydrodynamics at small spatial scale.

Marine environmental research·2015
Same author

Linked Records of Children with Traumatic Brain Injury. Probabilistic Linkage without Use of Protected Health Information.

Methods of information in medicine·2015
Same author

Potential neuroprotective strategies for perinatal infection and inflammation.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2015

Area of Science:

  • Toxicology
  • Nephrology
  • Experimental Medicine

Background:

  • Iron intoxication is a life-threatening condition requiring effective removal strategies.
  • Deferoxamine is a chelating agent used to treat iron overload.
  • Continuous arteriovenous hemofiltration (CAVH) is a renal replacement therapy with potential for toxin removal.

Purpose of the Study:

  • To evaluate the efficacy of CAVH in removing the iron-deferoxamine complex.
  • To assess the impact of deferoxamine dosage on iron removal via CAVH.
  • To investigate factors influencing the efficiency of iron-deferoxamine complex formation and removal.

Main Methods:

  • Experimental model using anesthetized dogs with induced iron intoxication (ferrous sulfate).
  • Hemodynamic monitoring and initiation of CAVH post-absorption period.

Related Experiment Videos

  • Infusion of deferoxamine into the CAVH circuit at escalating doses.
  • Measurement of iron and deferoxamine excretion in ultrafiltrate and urine.

    • Main Results:

    • A dose-dependent increase in iron excretion in the CAVH ultrafiltrate was observed.
    • A significant portion of deferoxamine was excreted unbound, suggesting incomplete complexation.
    • Lower blood pressure and ultrafiltration rates correlated with increased complex formation efficiency.
    • Urinary iron excretion was not significantly higher than iron removed by CAVH.

    Conclusions:

    • CAVH is a viable method for removing iron-deferoxamine complexes in experimental iron intoxication.
    • Arterial administration of deferoxamine may lead to suboptimal mixing and complexation.
    • Further research is needed to optimize deferoxamine delivery and CAVH parameters for enhanced iron chelation therapy.